Strategy for post-Brexit life science sector unveiled
Plan aims to solve long-standing issue of access to medicines
X
Strategy for post-Brexit life science sector unveiled
https://pharmaphorum.com/news/uk-government-unveils-life-sciences-strategy/
Accelerated Access Review
New funding to improve NHS tech adoption
New £86 million fund aims to speed up patient access to innovative digital technologies.
Disappointment as government delays pharma-friendly policies
Proposals fall short of ambitions of Accelerated Access Review.
UK must draw up post-Brexit pharma strategy
Big pharma could take its money elsewhere post Brexit, report warns.
UK aims to cut four years from drug development process
NICE, regulator and NHS should work together, according to review.
Accelerated Access Review: no panacea for UK pharma
What can the AAR do for the UK pharma industry, the health service and patients?
